Literature DB >> 15592285

Interferon alfa treatment for pregnant women affected by essential thrombocythemia: case reports and a review.

Pasquale Martinelli1, Vincenzo Martinelli, Annalisa Agangi, Giuseppe Maria Maruotti, Dario Paladini, Rosanna Ciancia, Bruno Rotoli.   

Abstract

OBJECTIVES: In the past essential thrombocythemia was considered a disease of the elderly. At present, the number of young people suffering from this disease is growing, with a slightly higher frequency in females. We investigated the effects of interferon alfa therapy in these patients. STUDY
DESIGN: We describe 9 pregnancies in 4 women affected by essential thrombocythemia.
RESULTS: Four pregnancies were carried out without interferon alfa therapy, and resulted in 2 intrauterine deaths, 1 spontaneous abortion, and 1 neonatal death. Interferon alfa was given during another 5 pregnancies; among them, 2 ended in preterm deliveries with normal infants, and 3 in full-term deliveries. The literature is reviewed.
CONCLUSION: Our cases and published series suggest that fetal outcome is improved by therapy, and that interferon alfa may be the best therapeutic option.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15592285     DOI: 10.1016/j.ajog.2004.05.001

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  6 in total

Review 1.  Efficacy and safety of interferon alpha for essential thrombocythemia during pregnancy: two cases and a literature review.

Authors:  Kazuya Sakai; Akane Ueda; Masaaki Hasegawa; Yasunori Ueda
Journal:  Int J Hematol       Date:  2017-12-30       Impact factor: 2.490

2.  Interferon alpha for essential thrombocythemia during 34 high-risk pregnancies: outcome and safety.

Authors:  Lukas Schrickel; Florian H Heidel; Parvis Sadjadian; Tatjana Becker; Vera Kolatzki; Andreas Hochhaus; Martin Griesshammer; Kai Wille
Journal:  J Cancer Res Clin Oncol       Date:  2020-11-02       Impact factor: 4.553

Review 3.  Essential thrombocythemia.

Authors:  Jean B Brière
Journal:  Orphanet J Rare Dis       Date:  2007-01-08       Impact factor: 4.123

4.  Outcome of Pregnancy in the Era of Pegylated Interferon Alpha 2a in Females with Essential Thrombocythemia: An Experience from Qatar.

Authors:  Mohammad Abu-Tineh; Nancy Kassem; Mohammad Abdul-Jaber Abdulla; Omar Mohammad Ismail; Rola Ghasoub; Mahmood B Aldapt; Mohamed A Yassin
Journal:  Case Rep Oncol       Date:  2020-03-26

Review 5.  Guidelines for the management of myeloproliferative neoplasms.

Authors:  Chul Won Choi; Soo-Mee Bang; Seongsoo Jang; Chul Won Jung; Hee-Jin Kim; Ho Young Kim; Soo-Jeong Kim; Yeo-Kyeoung Kim; Jinny Park; Jong-Ho Won
Journal:  Korean J Intern Med       Date:  2015-10-30       Impact factor: 2.884

Review 6.  The 2020 revision of the guidelines for the management of myeloproliferative neoplasms.

Authors:  Sung-Yong Kim; Sung Hwa Bae; Soo-Mee Bang; Ki-Seong Eom; Junshik Hong; Seongsoo Jang; Chul Won Jung; Hee-Jin Kim; Ho Young Kim; Min Kyoung Kim; Soo-Jeong Kim; Yeung-Chul Mun; Seung-Hyun Nam; Jinny Park; Jong-Ho Won; Chul Won Choi
Journal:  Korean J Intern Med       Date:  2020-12-04       Impact factor: 2.884

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.